182 related articles for article (PubMed ID: 31855206)
1. [Local drugs in treating and decreasing the incidence of adverse reactions after sclerotherapy of telangiectasia].
Bogachev VI; Boldin BV; Turkin PI; Lobanov VN
Angiol Sosud Khir; 2019; 25(4):102-107. PubMed ID: 31855206
[TBL] [Abstract][Full Text] [Related]
2. [Cryocompression sclerotherapy of reticular veins and teleangiectasias].
Bogachev VI; Kuznetsov MR; Lobanov VN; Turkin PI
Angiol Sosud Khir; 2018; 24(3):92-97. PubMed ID: 30321152
[TBL] [Abstract][Full Text] [Related]
3. Reducing hyperpigmentation after sclerotherapy: A randomized clinical trial.
Gonzalez Ochoa AJ; Carrillo J; Manríquez D; Manrique F; Vazquez AN
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):154-162. PubMed ID: 32739509
[TBL] [Abstract][Full Text] [Related]
4. Skin hyperpigmentation after sclerotherapy with polidocanol: A systematic review.
Bossart S; Daneluzzi C; Cazzaniga S; Ramelet AA; Uthoff H; Seyed Jafari SM; Baumgartner M; Hunger RE; Heidemeyer K; Willenberg T
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):274-283. PubMed ID: 36196455
[TBL] [Abstract][Full Text] [Related]
5. Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study.
Kern P; Ramelet AA; Wütschert R; Hayoz D
J Vasc Surg; 2007 Jun; 45(6):1212-6. PubMed ID: 17467226
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of short-term compression after sclerotherapy for telangiectatic varicose veins.
Bayer A; Kuznik N; Langan EA; Recke A; Recke AL; Faerber G; Kaschwich M; Kleemann M; Kahle B
J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):435-443. PubMed ID: 32502730
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, randomized study comparing pure chromated glycerin with chromated glycerin with 1% lidocaine and epinephrine for sclerotherapy of telangiectasias and reticular veins.
Kern P; Ramelet AA; Wutschert R; Mazzolai L
Dermatol Surg; 2011 Nov; 37(11):1590-4. PubMed ID: 21883648
[TBL] [Abstract][Full Text] [Related]
8. Sclerotherapy in tumescent anesthesia of reticular veins and telangiectasias.
Ramelet AA
Dermatol Surg; 2012 May; 38(5):748-51. PubMed ID: 22268802
[TBL] [Abstract][Full Text] [Related]
9. Sclerotherapy of varicose and telangiectatic leg veins. Minimal sclerosant concentration of hypertonic saline and its relationship to vessel diameter.
Sadick NS
J Dermatol Surg Oncol; 1991 Jan; 17(1):65-70. PubMed ID: 1991883
[TBL] [Abstract][Full Text] [Related]
10. A comparative study between cryo-laser cryo-sclerotherapy and sclerotherapy in the treatment of telangiectasia and reticular veins: A randomized controlled trial.
Nasser MM; Ghoneim BM; Eldaly W; Elmahdy H
J Vasc Surg Venous Lymphat Disord; 2024 Jul; 12(4):101874. PubMed ID: 38522666
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous hyperpigmentation following venous sclerotherapy treated with deferoxamine mesylate.
Lopez L; Dilley RB; Henriquez JA
Dermatol Surg; 2001 Sep; 27(9):795-8. PubMed ID: 11553167
[TBL] [Abstract][Full Text] [Related]
12. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
Willenberg T; Smith PC; Shepherd A; Davies AH
Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
[TBL] [Abstract][Full Text] [Related]
13. Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial.
Bertanha M; Sobreira ML; Pinheiro Lúcio Filho CE; de Oliveira Mariúba JV; Farres Pimenta RE; Jaldin RG; Moroz A; Moura R; Rollo HA; Yoshida WB
Trials; 2014 Dec; 15():497. PubMed ID: 25527165
[TBL] [Abstract][Full Text] [Related]
14. Management of reticular veins and telangiectases.
Smith PC
Phlebology; 2015 Nov; 30(2 Suppl):46-52. PubMed ID: 26556703
[TBL] [Abstract][Full Text] [Related]
15. Complications of sclerotherapy.
Munavalli GS; Weiss RA
Semin Cutan Med Surg; 2007 Mar; 26(1):22-8. PubMed ID: 17349559
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of graduated compression stockings for an additional 3 weeks after sclerotherapy treatment of reticular and telangiectatic leg veins.
Nootheti PK; Cadag KM; Magpantay A; Goldman MP
Dermatol Surg; 2009 Jan; 35(1):53-7; discussion 57-8. PubMed ID: 19067733
[TBL] [Abstract][Full Text] [Related]
17. Nd:Yag laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias (CLaCS method): A triple-blind randomized clinical trial comparing two sclerosing agents associated with same laser patterns.
Fonseca MM; Mocelin FJ; Grill MH; Gianesini S; Miyake K; Argenta R; Pereira AH
Phlebology; 2023 Apr; 38(3):165-171. PubMed ID: 36657386
[TBL] [Abstract][Full Text] [Related]
18. Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonic saline vs. polidocanol.
Weiss RA; Weiss MA
J Dermatol Surg Oncol; 1990 Sep; 16(9):800-4. PubMed ID: 2398199
[TBL] [Abstract][Full Text] [Related]
19. Post-procedural Compression vs. No Compression After Radiofrequency Ablation and Concomitant Foam Sclerotherapy of Varicose Veins: A Randomised Controlled Non-inferiority Trial.
Pihlaja T; Romsi P; Ohtonen P; Jounila J; Pokela M
Eur J Vasc Endovasc Surg; 2020 Jan; 59(1):73-80. PubMed ID: 31753745
[TBL] [Abstract][Full Text] [Related]
20. Safety Concerns for Sclerotherapy of Telangiectases, Reticular and Varicose Veins.
Yiannakopoulou E
Pharmacology; 2016; 98(1-2):62-9. PubMed ID: 27104778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
